Quantcast

Latest radiation therapy Stories

2014-08-19 23:06:59

Clarity builds online interface and provides affiliated patient safety services for a new patient safety initiative in radiation oncology care. Chicago, IL (PRWEB) August 19, 2014 Clarity Group and Clarity PSO, an operating division of Clarity Group, are proud to announce that the company has been selected by the American Society for Radiation Oncology (ASTRO) and the American Association of Physicists in Medicine (AAPM) for a key role in the development and launch of RO-ILS: Radiation...

2014-08-15 23:06:41

AccuBoost Announces First Breast Cancer Patient Treatments at the Midwestern Regional Medical Center in Zion, IL Tyngsboro, MA (PRWEB) August 15, 2014 Advanced Radiation Therapy, creators of the AccuBoost Breast Brachytherapy technology, is pleased to announce that it has entered into an agreement with the Midwestern Regional Medical Center of Zion, IL to offer the AccuBoost treatment option to their patients undergoing breast conservation therapy (BCT). Treatments utilizing the AccuBoost...

Cancer cell containing nanoparticles
2014-08-14 03:00:53

University of Cambridge A smart technology which involves smuggling gold nanoparticle into brain cancer cells has proven highly effective in lab-based tests A "Trojan horse" treatment for an aggressive form of brain cancer, which involves using tiny nanoparticles of gold to kill tumor cells, has been successfully tested by scientists. The ground-breaking technique could eventually be used to treat glioblastoma multiforme, which is the most common and aggressive brain tumor in adults,...

2014-08-14 08:30:20

Company Strengthens Intellectual Property Protection in Additional Global Market DALLAS and NEW YORK, Aug. 14, 2014 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, has received notification from the Japan Patent Office that a patent for MuGard and ProctiGard has been granted. The patent covers a wide range of liquid formulations for the prevention and treatment of mucosal diseases and disorders. "Following our recent European...

2014-08-12 08:29:40

IRVING, Texas, Aug. 12, 2014 /PRNewswire/ -- Doctors at the LSU Health Shreveport Feist-Weiller Cancer Center will now have access to innovative, precision-medicine technology that determines the unique biological characteristics of each individual patient's cancer tumor. Once that information is known, physicians can identify tailored chemotherapy or radiation regimens to attack it. The new capability is the result of emerging technology called tumor profiling. Feist-Weiller will...

2014-08-11 16:27:26

PALO ALTO, Calif., Aug. 11, 2014 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) will hold a meeting for investors on Tuesday, September 16, at the annual meeting of the American Society for Radiation Oncology (ASTRO) in San Francisco. Varian will host a meeting with management, beginning with breakfast at 7:30 a.m. and webcast presentations from 8:00 a.m. to 10:00 a.m. on Tuesday at the San Francisco Marriott Marquis, 780 Mission Street, in the Nob Hill meeting room....

2014-08-11 08:29:26

TrueBeam STx expands radiation oncology services, offers patients shorter treatment time CHARLESTON, S.C., Aug. 11, 2014 /PRNewswire/ -- New technology installed at the Medical University of South Carolina Hollings Cancer Center offers patients a nonsurgical, specialized form of treatment that can be completed in five or fewer outpatient sessions, each lasting 20 minutes or less. The first patient will be treated on Aug. 13. http://photos.prnewswire.com/prnvar/20140808/134796 An...

2014-08-07 23:09:09

NuvOx Pharma, a Tucson based biotechnology company, began a Phase Ib clinical trial of its new drug NVX-108 in patients with glioblastoma, a deadly form of brain cancer. Tucson, AZ (PRWEB) August 07, 2014 NuvOx Pharma, a privately held biotechnology company based in Tucson, Arizona, focused on developing a nanotechnology platform for reversing conditions with decreased oxygen announced that on July 14th, it began a Phase Ib clinical trial of its new drug NVX-108 in patients with...

2014-07-31 23:05:46

The ANS Skull Base Surgery Center offers hope for patients who suffer from brain tumors, acoustic neuromas, pituitary tumors, skull base meningiomas, trigeminal neuralgia, spinal fluid leaks, and aneurysms. Morristown, NJ (PRWEB) July 31, 2014 ANS and Dr. Yaron Moshel offer answers to some common questions they receive about the ANS Skull Base Center and what the future holds for Brain Tumor Surgery. What is the ANS Skull Base Surgery Center? Skull base surgery is a form of highly...

2014-07-31 08:36:39

First MRI-Guided Radiation Therapy System to be installed on the U.S. Eastern Seaboard CLEVELAND, July 31, 2014 /PRNewswire/ -- The Sylvester Comprehensive Cancer Center at the University of Miami has become the fourth U.S. customer and the first hospital on the east coast to acquire an MRI-guided radiation therapy system from ViewRay(TM) Incorporated, a privately held medical device company. The MRIdian(TM) (me-rid-i-an) system is the first and only FDA cleared system of its kind...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related